MedTrace Logo

Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis

NCT01893905 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2017-08-04

Study results available
· View outcomes & findings →

Summary

The main objective is to assess the efficacy of a new formulation containing chondroitin sulfate and glucosamine sulfate (CS+GS) compared with placebo in patients with primary osteoarthritis of the knee.

Conditions

Interventions

DRUG

CS+SG

Chondroitin sulfate+glucosamine sulfate orally administered once a day for 24 weeks.

DRUG

Placebo

Placebo of chondroitin sulfate+glucosamine sulfate orally administered once a day for 24 weeks.

Sponsors & Collaborators

  • Tedec-Meiji Farma, S.A.

    lead INDUSTRY

Principal Investigators

  • FJ Blanco, M.D. · Complejo Hospitalario Universitario La Coruña

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893905 on ClinicalTrials.gov